Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
Université de Montréal · Cancer Research UK · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
809
total citations
- FWCI
- 20.44
- Percentile
- 100%
- References
- 48
Citations per year
Authors
18- FSFred SaadCorresponding
Université de Montréal
- JEJanet E. Brown
Cancer Research UK, University of Leeds
- CVCatherine Van Poznak
Michigan Center for Translational Pathology, University of Michigan–Ann Arbor
- TIToni Ibrahim
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
- SMSalomon M. Stemmer
Rabin Medical Center
Topics & keywords
Topics
Keywords
- Medicine
- Osteonecrosis of the jaw
- Denosumab
- Zoledronic acid
- Incidence (geometry)
- Internal medicine
- Surgery
- Bisphosphonate
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.